lipid nanoparticle-formulated mRNA vaccine (CureVac/CEPI)

N/A

Report date: 2025/12/12 17:32:02

Base Information

Drug Namelipid nanoparticle-formulated mRNA vaccine (CureVac/CEPI)
Drug Alias NameLNP-mRNA vaccine (CureVac/CEPI)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLassa FeverYellow Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNorwayGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCoalition for Epidemic Preparedness Innovations
China Registration ClassN/A

Develop Information

Active CompaniesCureVac NVCoalition for Epidemic Preparedness Innovations
Inactive CompaniesN/A
Active IndicationsLassa FeverYellow Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A